INS and Hyperglycemia: Further development of the SAP are the hybrid systems (hybrid closed loop, HCL), in which the basal insulin infusion is modified in response to hyperglycemia or hypoglycemia prediction, and the fully automatic artificial pancreas (AP), in which there is an automatic connection between CGM and CSII through an algorithm which is installed on a chip or a device.